Cannabis Report
Home > Boards > US Listed > Biotechs >

MERSANA THERAPEUTICS, INC. (MRSN)

MRSN RSS Feed
Add MRSN Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 9/5/2018 9:50:11 PM - Followers: 3 - Board type: Free - Posts Today: 0

Mersana Therapeutics, Inc. is a biotechnology company that discovers, engineers, and develops antibody drug conjugates to cure various cancers. The company develops immune conjugate therapies to create drugs that enhance patients’ lives. It offers XMT-1522, a drug therapy for tumor models that express relatively low amounts of the HER2 protein; and human anti-HER2 antibody used in XMT-1522. Mersana Therapeutics, Inc. has strategic alliances with Takeda Pharmaceutical Company Limited; Merck Serono; and Asana BioSciences. The company was formerly known as Nanopharma Corp. and changed its name to Mersana Therapeutics, Inc. in November 2005. Mersana Therapeutics, Inc. was founded in 2001 and is based in Cambridge, Massachusetts.
Cannabis Report
MRSN
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
MRSN News: Notice of Effectiveness (effect) 09/18/2018 06:02:06 AM
MRSN News: Current Report Filing (8-k) 09/17/2018 08:02:16 AM
MRSN News: Mersana Announces FDA Lifts Partial Clinical Hold for XMT-1522 09/17/2018 07:00:00 AM
MRSN News: Securities Registration Statement (simplified Form) (s-3/a) 09/14/2018 08:41:42 AM
MRSN News: Mersana Therapeutics to Present at Upcoming Investor Conferences 08/30/2018 04:01:00 PM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
PostSubject
#24   Abstract out for WCLC..... jaybe 09/05/18 09:50:11 PM
#23   I would add here if I hadn't loaded jaybe 07/19/18 10:17:08 AM
#22   Mersana...after ASCO... jaybe 06/07/18 12:33:33 PM
#21   New patent app published for new linker/scaffold... jaybe 05/31/18 11:37:13 AM
#20   It appears that we have the right CEO. dorothy52 05/27/18 12:21:39 PM
#19   Good read on CEO Protopapas's path to Mersana... jaybe 05/26/18 12:01:54 PM
#18   Exactly. Looking forward to pre-clinical on next jaybe 05/12/18 04:55:53 PM
#17   The prize is in the platform/technology. Stay tune dorothy52 05/11/18 06:33:55 PM
#16   Another Her2 ADC competitor down for the count.... jaybe 04/24/18 10:01:57 PM
#15   Mersana ex-CMO lands at Relay Therapeutics.... jaybe 04/05/18 10:40:02 AM
#14   XMT-1522 Late-breaker at AACR in April... jaybe 03/14/18 11:39:53 PM
#13   Potential competitor MEDI4276 flames out... jaybe 03/08/18 10:29:38 PM
#12   Thanks for the updates jaybe dorothy52 03/07/18 05:40:47 PM
#11   Article in ADC Review notes Mersana's progress... jaybe 02/03/18 06:05:16 PM
#10   Notes from JPM: Moving forward on all fronts... jaybe 01/12/18 11:15:57 AM
#9   Poster from today's presentation at AACR-EORTC available here... jaybe 10/29/17 03:25:11 PM
#8   Okay I get it. Wonder how trial is dorothy52 10/03/17 07:44:16 PM
#7   That’s $2B in bio-bucks right? This will be jaybe 10/03/17 07:00:36 PM
#6   There's about 25 million shares right? So with dorothy52 10/03/17 05:17:51 PM
#5   PE’s are all over the map, I mean jaybe 10/03/17 02:55:10 PM
#4   All green for me as well. 10 bagger? dorothy52 10/03/17 02:16:11 PM
#3   Mersana picks up 'Best New Drug Developer' at jaybe 09/22/17 10:06:48 PM
#2   Should see analyst coverage Monday...expiration of quiet period.. jaybe 07/21/17 10:19:00 PM
#1   MRSN...all green lights for me... jaybe 07/16/17 02:36:27 PM
PostSubject